(Q53066017)

English

Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.

scientific article published on 14 May 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

circulatory system

1 reference

based on heuristic

inferred from title

Toshihisa Anzai

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

author name string

Takayuki Ise

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Takuya Hasegawa

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Yoshiaki Morita

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Naoaki Yamada

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Akira Funada

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Hiroyuki Takahama

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Makoto Amaki

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Hideaki Kanzaki

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Hideo Okamura

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Shiro Kamakura

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Wataru Shimizu

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Masafumi Kitakaze

13

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

language of work or name

0 references

publication date

14 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

100

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

15

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

1165-1172

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

Bone and joint sarcoidosis

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Sarcoidosis of the heart

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Myocardial sarcoidosis

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Detection of myocardial damage in patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Revised equations for estimated GFR from serum creatinine in Japan

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-305187

21 January 2018

Identifiers

10.1136/HEARTJNL-2013-305187

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24829369

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53066017&oldid=1237123319"